Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethel D Weld

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Viral Hepatitis|November 15, 2024
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income CountriesRenae Furl, Kimberly K Scarsi, Harlan Sayles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multiparametric magnetic resonance imaging to characterize cabotegravir long-acting formulation depot kinetics in healthy adult volunteersBeat M Jucker, Edward J Fuchs, Sarah Lee, et al.
AIDS (London, England)|March 6, 2026
Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosingCraig W Hendrix, Sharon L Hillier, Linda-Gail Bekker, et al.
The Journal of Infectious Diseases|November 29, 2023
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)Ethel D Weld, Ian McGowan, Peter Anton, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Viral Hepatitis|November 15, 2024
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income CountriesRenae Furl, Kimberly K Scarsi, Harlan Sayles, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multiparametric magnetic resonance imaging to characterize cabotegravir long-acting formulation depot kinetics in healthy adult volunteersBeat M Jucker, Edward J Fuchs, Sarah Lee, et al.
AIDS (London, England)|March 6, 2026
Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosingCraig W Hendrix, Sharon L Hillier, Linda-Gail Bekker, et al.
The Journal of Infectious Diseases|November 29, 2023
Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)Ethel D Weld, Ian McGowan, Peter Anton, et al.
Nature Communications|June 8, 2026
5' leader defects drive persistent HIV-1 viremia on long-term ARTJulia R Box, Angelica Camilo-Contreras, Filippo Dragoni, et al.
Pageof 4